ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $139,000 | -40.1% | 213,560 | +0.3% | 0.00% | – |
| Q4 2021 | $232,000 | -44.5% | 212,860 | -7.4% | 0.00% | – |
| Q3 2021 | $418,000 | -34.1% | 229,760 | -4.4% | 0.00% | – |
| Q2 2021 | $634,000 | -19.1% | 240,228 | +10.3% | 0.00% | – |
| Q1 2021 | $784,000 | +75.8% | 217,728 | +23.0% | 0.00% | – |
| Q4 2020 | $446,000 | -14.7% | 177,028 | -14.7% | 0.00% | – |
| Q3 2020 | $523,000 | -27.6% | 207,528 | -5.7% | 0.00% | – |
| Q2 2020 | $722,000 | +39.4% | 220,128 | +4.1% | 0.00% | – |
| Q1 2020 | $518,000 | -50.5% | 211,528 | -4.6% | 0.00% | -100.0% |
| Q4 2019 | $1,046,000 | +4.7% | 221,660 | -5.0% | 0.00% | 0.0% |
| Q3 2019 | $999,000 | -26.5% | 233,360 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,360,000 | +48.8% | 233,360 | -1.7% | 0.00% | 0.0% |
| Q1 2019 | $914,000 | +76.4% | 237,392 | -14.3% | 0.00% | – |
| Q4 2018 | $518,000 | -41.7% | 276,971 | -0.3% | 0.00% | -100.0% |
| Q3 2018 | $889,000 | +25.7% | 277,830 | +18.6% | 0.00% | – |
| Q2 2018 | $707,000 | -7.3% | 234,219 | +20.4% | 0.00% | -100.0% |
| Q1 2018 | $763,000 | -5.2% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $805,000 | -32.6% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,194,000 | -1.3% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,210,000 | -1.9% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,233,000 | +18.4% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,041,000 | -4.9% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,095,000 | +2.5% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,068,000 | -26.0% | 194,519 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,443,000 | -9.6% | 194,519 | +1.3% | 0.00% | 0.0% |
| Q4 2015 | $1,596,000 | -9.2% | 192,019 | -1.5% | 0.00% | -50.0% |
| Q3 2015 | $1,757,000 | -25.0% | 194,988 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,342,000 | +78.1% | 195,197 | +59.9% | 0.00% | +100.0% |
| Q1 2015 | $1,315,000 | +167.3% | 122,100 | +25.9% | 0.00% | – |
| Q4 2014 | $492,000 | +92.2% | 97,000 | 0.0% | 0.00% | – |
| Q3 2014 | $256,000 | -34.5% | 97,000 | 0.0% | 0.00% | – |
| Q2 2014 | $391,000 | -3.0% | 97,000 | +10.2% | 0.00% | – |
| Q1 2014 | $403,000 | -9.4% | 88,017 | -14.1% | 0.00% | – |
| Q4 2013 | $445,000 | +9.9% | 102,515 | 0.0% | 0.00% | – |
| Q3 2013 | $405,000 | +66.7% | 102,515 | -11.5% | 0.00% | – |
| Q2 2013 | $243,000 | – | 115,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |